Schedule Your FREE Consultation Today
Tarifs avantageux Nous vous offrons le meilleur tarif du march, alliant qualit et fiabilit
Tesamorelin Peptide Regulatory Status in Canada Health Canada Approval Status (Egrifta and Egrifta SV) Tesamorelin is the active ingredient in Egrifta, an approved prescription drug product authorized by Health Canada under a Notice of Compliance issued April 29, 2014, to Theratechnologies Inc
On July 23, the committee recommended that BPC-157 be moved to the list so that the peptide can be legally prescribed and compounded in the future
As of May 2025, heres the pricing: Single Shot: $25 Package Deal: Buy 3 shots for $75 and get the 4th one FREE!This makes ER Wellness one of the most affordable and accessible places in the area for regular B12 injections
It is not approved for use as a drug, food, cosmetic, or medical product, and is not intended for human or animal consumption